Home Clinical Research Current Clinical Trails A Phase 1b/2, Open-Label, Randomized Platform Study Evaluating the Efficacy and Safety of AB928-Based Treatment Combinations in Patients with Metastatic Castrate Resistant Prostate Cancer

Arc 6

Condition: Metastatic Castrate Resistant Prostate Cancer | Last Updated: | Status:

View Full Study

Cancer Treatment Team

Meet Our Team

Learn more about our Cancer Treatment Team by scrolling below, or visit our Meet the Team page.

Arvind Chaudhry, MD, PhD

Medical Oncologist

Mirela Andrei, MD

Medical Oncologist

Deepthi Kodali, MD

Medical Oncologist

Aaron Saunders, MD, MAS, FACS, FSSO

Chief of Surgical Oncology

Max Seaton, MD

Surgical Oncologist

Jing Li Huang, MD

Surgical Oncologist

Kimberly Grome, PA-C

Medical Oncology

Makena Turner, PA-C

Medical Oncology

Annalee Wilson, MN, ARNP

Medical Oncology

Mackenzi Heaton, ARNP

Medical Oncology

Brianne Ozaki, ARNP

Surgical Oncology

Madison McDonald, PA-C

Surgical Oncology